Published in Oncogene on January 04, 2001
Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. Proc Natl Acad Sci U S A (2005) 1.72
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology (2009) 1.35
Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci U S A (2002) 1.27
IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation. EMBO J (2002) 1.26
Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J (2005) 1.20
Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics (2006) 1.08
Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome. Mol Cancer (2005) 1.05
Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1. J Biol Chem (2002) 1.02
ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response. Cell Death Differ (2010) 1.01
Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 gene. J Virol (2006) 0.97
Immediate early gene X-1 interacts with proteins that modulate apoptosis. Biochem Biophys Res Commun (2004) 0.96
Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm Bowel Dis (2010) 0.93
Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer. BMC Med Genomics (2010) 0.93
Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. Am J Pathol (2010) 0.88
Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett (2007) 0.88
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells. Br J Cancer (2001) 0.85
Immediate early response gene X-1, a potential prognostic biomarker in cancers. Expert Opin Ther Targets (2013) 0.85
Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity. Mol Cell Biol (2003) 0.85
A novel vitamin D-regulated immediate-early gene, IEX-1, alters cellular growth and apoptosis. Recent Results Cancer Res (2003) 0.85
Immediate early gene-X1 interferes with 26 S proteasome activity by attenuating expression of the 19 S proteasomal components S5a/Rpn10 and S1/Rpn2. Biochem J (2007) 0.83
The role of Iex-1 in the pathogenesis of venous neointimal hyperplasia associated with hemodialysis arteriovenous fistula. PLoS One (2014) 0.83
Differentiation potential of pancreatic fibroblastoid cells/stellate cells: effects of peroxisome proliferator-activated receptor gamma ligands. Int J Cell Biol (2011) 0.82
Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyopathy. Int J Mol Sci (2017) 0.75
Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells. Oncogene (2016) 0.75
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem (1993) 2.93
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Identification of and spatio-temporal differences between microbial assemblages from two neighboring sulfurous lakes: comparison by microscopy and denaturing gradient gel electrophoresis. Appl Environ Microbiol (2000) 2.51
[MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)]. Dtsch Med Wochenschr (1974) 2.50
Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut (1996) 2.41
Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J (1997) 2.33
Phytoalexin synthesis in soybean cells: elicitor induction of phenylalanine ammonia-lyase and chalcone synthase mRNAs and correlation with phytoalexin accumulation. Arch Biochem Biophys (1984) 2.22
Influence of lipid/peptide hydrophobic mismatch on the thickness of diacylphosphatidylcholine bilayers. A 2H NMR and ESR study using designed transmembrane alpha-helical peptides and gramicidin A. Biochemistry (1998) 2.07
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
High-affinity binding of fungal beta-glucan fragments to soybean (Glycine max L.) microsomal fractions and protoplasts. Eur J Biochem (1988) 1.84
Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol (1986) 1.83
Validity of western immunoblot band patterns in the serodiagnosis of Lyme borreliosis. J Clin Microbiol (1991) 1.79
Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J Biol Chem (1999) 1.70
An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg (1997) 1.68
Necrotizing lymphadenitis: Kikuchi--Fujimoto disease alias lupus lymphadenitis? Lupus (2009) 1.67
Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia (1985) 1.67
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia. Diabetologia (2003) 1.56
The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells. Eur J Clin Invest (2002) 1.56
Exploring the genetic link between RLS and ADHD. J Psychiatr Res (2009) 1.55
Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics (2001) 1.53
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut (1996) 1.53
Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol (1998) 1.49
Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially misdiagnosed as autoimmune hepatitis. Scand J Gastroenterol (2001) 1.47
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene (2001) 1.46
Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know? Rheumatology (Oxford) (2008) 1.45
[Regional adjuvant therapy in colorectal liver metastases: requirements for clinical therapy studies from the statistical viewpoint]. Zentralbl Chir (1995) 1.44
Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia (2010) 1.41
Primary sclerosing cholangitis mimicking choledocal cyst type 1 in a young patient. Endoscopy (1999) 1.41
[Hepatosplenomegaly]. Internist (Berl) (1994) 1.40
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut (2002) 1.40
Familial clustering of infantile cirrhosis in Northern Germany: A clue to the etiology of idiopathic copper toxicosis. J Pediatr (1999) 1.39
[Therapy of chronic pancreatitis]. Dtsch Med Wochenschr (1996) 1.39
Systemic effects and side effects of interstitial techniques used in liver tissue. J Am Coll Surg (1999) 1.39
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut (2006) 1.36
Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry (2010) 1.33
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene (2009) 1.32
Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept (2001) 1.30
Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme. Diabetes Obes Metab (2011) 1.29
A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry (2006) 1.29
The response of the microbial community of marine sediments to organic carbon input under anaerobic conditions. Syst Appl Microbiol (1999) 1.28
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene (2006) 1.27
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia (2006) 1.26
Role of Candida albicans in granulomatous tissue reactions. II. In vivo degradation of C. albicans in hepatic macrophages of mice. J Infect Dis (1977) 1.23
Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Gut (2007) 1.22
The beta-peptide hairpin in solution: conformational study of a beta-hexapeptide in methanol by NMR spectroscopy and MD simulation. J Am Chem Soc (2001) 1.22
Solid-state NMR determination of the secondary structure of Samia cynthia ricini silk. Nature (2000) 1.21
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium. Clin Exp Immunol (1990) 1.20
Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol Psychiatry (2008) 1.18
Enteral long-term nutrition via percutaneous endoscopic gastrostomy (PEG) in 210 patients: a four-year prospective study. Dig Dis Sci (1998) 1.17
Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. J Clin Endocrinol Metab (1989) 1.17
Impulsive terahertz radiation with high electric fields from an amplifier-driven large-area photoconductive antenna. Opt Express (2010) 1.17
Accelerated titering of adenoviruses. Biotechniques (2000) 1.16
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol (2001) 1.13
Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J (1998) 1.13
European Cooperative Crohn's Disease Study (ECCDS): clinical features and natural history. Digestion (1985) 1.11
Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut (2002) 1.11
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects. Diabetologia (2007) 1.10
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene (2001) 1.10
FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun (2001) 1.10
FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. J Cell Sci (2001) 1.10
Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Heart (2004) 1.09
Ultrafast transient generation of spin-density-wave order in the normal state of BaFe2As2 driven by coherent lattice vibrations. Nat Mater (2012) 1.09
Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry (2005) 1.09
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia (2012) 1.08
Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats. Diabetologia (1984) 1.07
NFkappaB-dependent chemoresistance in solid tumors. Int J Clin Pharmacol Ther (2002) 1.07
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia (2006) 1.06
Functional expression of HGF and its receptor in human colorectal cancer. Digestion (2000) 1.05
Pancreatic enzyme response to secretin and cholecystokinin-pancreozymin in the rat. J Physiol (1973) 1.05
Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab. Pharmacogenomics J (2002) 1.05
Dynamics of photoinduced charge-density-wave to metal phase transition in K0.3MoO3. Phys Rev Lett (2009) 1.05
Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med (1997) 1.05
Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil (2006) 1.05
Is there still a need for living-related liver transplantation in children? Ann Surg (2001) 1.04
Animal experimental studies on chronic granulomatous inflammation and T-lymphocyte-system. Beitr Pathol (1975) 1.03
Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split products. J Infect Dis (1977) 1.03
Mechanisms in failure of infliximab for Crohn's disease. Lancet (2000) 1.03
[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol (2012) 1.02
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J (2005) 1.01
Chylous cardiac tamponade in acute pancreatitis. Dig Dis Sci (1996) 1.01
Does treatment of varicocele improve male fertility? results of the 'Deutsche Varikozelenstudie', a multicentre study of 14 collaborating centres. Andrologia (2002) 1.01
[Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)]. Dtsch Med Wochenschr (1975) 1.01
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma. Recent Results Cancer Res (2008) 1.01
Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index. J Med Genet (2004) 1.01
The pancreatic secretion of enzymes in rats treated with soybean diet. Scand J Gastroenterol (1974) 1.00
[Identification of human porins. II. Characterization and primary structure of a 31-lDa porin from human B lymphocytes (Porin 31HL)]. Biol Chem Hoppe Seyler (1989) 0.99
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Oncogene (2007) 0.99
The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB. FEBS Lett (1998) 0.99
Development of the hormone-sensitive glucose transport activity in differentiating 3T3-L1 murine fibroblasts. Role of the two transporter species and their subcellular localization. Biochem J (1990) 0.99
Prenatal diagnosis of carbamoyl phosphate synthetase I deficiency by identification of a missense mutation in CPS1. Hum Mutat (1998) 0.99